Your source for the latest medtech news from AdvaMed and our members.
Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that Wendy Siminski has joined the association as its new Senior Vice President for Conferences and Events. This is…
WASHINGTON, D.C. – AdvaMed Accel – the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical technology manufacturers – announced that Martha Shadan, executive chairwoman…
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses on the value diagnostics bring to patients’ health and health care, while addressing the need for regulatory…
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that it has closed a transaction to fully own and operate The Medtech Conference, the premier global gathering of…
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-434-7233
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker following confirmation of Alex Azar as Secretary of the Department of…
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the passage of the current continuing resolution, which includes a…
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of…
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the proposed continuing resolution in the U.S. House:
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today on CMS guidance regarding Medicare Prescription Drug Part D coverage…